Raben David — SEC Form 4 filings
SEC reporting owner CIK 2034679. 7 Form 4 filings on record with FilingPulse; latest filed 2026-04-28.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2025-10-10 to 2026-04-28. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 8 legs across 5 filings — 60,500 shares, $1,146,678 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 19.
- Largest priced transaction: sale of 22,000 shares @ $18.45 ($405,900) in Bicara Therapeutics Inc., filed 2025-10-10.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Bicara Therapeutics Inc. (BCAX) | Chief Medical Officer | 7 | — | 8 legs · 60,500 sh · $1,146,678 | 19 |
Form 4 filings — Raben David
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-04-28 | 4 | Bicara Therapeutics Inc. (BCAX) | Option exercise (M): 5,500 @ $3.79 · Sale (S): 5,500 @ $22.88 · Option exercise (M): 5,500 (derivative) @ $0 | EDGAR |
| 2026-03-26 | 4 | Bicara Therapeutics Inc. (BCAX) | Option exercise (M): 5,500 @ $3.79 · Sale (S): 5,500 @ $18.95 · Option exercise (M): 5,500 (derivative) @ $0 | EDGAR |
| 2026-03-05 | 4 | Bicara Therapeutics Inc. (BCAX) | Option exercise (M): 200 @ $3.79 · Sale (S): 200 @ $18.45 · Option exercise (M): 16,300 @ $3.79 · Sale (S): 16,300 @ $18.52 · Option exercise (M): 200 (derivative) @ $0 · Option exercise (M): 16,300 (derivative) @ $0 | EDGAR |
| 2026-02-04 | 4 | Bicara Therapeutics Inc. (BCAX) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2025-12-29 | 4 | Bicara Therapeutics Inc. (BCAX) | Option exercise (M): 19,789 @ $3.79 · Option exercise (M): 19,789 (derivative) @ $0 | EDGAR |
| 2025-11-25 | 4 | Bicara Therapeutics Inc. (BCAX) | Option exercise (M): 5,500 @ $3.79 · Sale (S): 5,500 @ $18.45 · Option exercise (M): 4,594 @ $3.79 · Sale (S): 4,594 @ $18.84 · Option exercise (M): 906 @ $3.79 · Sale (S): 906 @ $18.84 · +3 more | EDGAR |
| 2025-10-10 | 4 | Bicara Therapeutics Inc. (BCAX) | Option exercise (M): 22,000 @ $3.79 · Sale (S): 22,000 @ $18.45 · Option exercise (M): 22,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2034679 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →